Burzynski: Cancer is Serious Business, Part II| 1hr : 46mins
Director: Eric Merola | Producer: Eric Merola
Focus Years: 2013 | Country: United States
In the compelling follow-up to 'Burzynski, the Movie', the internationally award-winning documentary, 'Burzynski: Cancer is Serious Business, Part II' explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas. For most patients undergoing Burzynski's treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many dead. As the story unfolds, the audience will observe a real-time change of hearts and minds from many of these doctors and families. Unlike the first documentary in the series, Part II showcases interviews with board-certified oncologists, surgeons and neurosurgeons, who witnessed patients leave their care, soon to return in great health after opting for the Burzynski Clinic. Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls "Personalized Gene-Targeted Cancer Therapy," where the patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient, as opposed to the conveyor belt, "one-size-fits-all" approach that current oncology adheres to. Due to the slow-moving, bureaucratic obstacles enforced on Antineoplastons by America's FDA, this new expanded "personalized gene-targeted" direction has allowed more patients (who are denied access to Antineoplastons) to benefit from Burzynski's practice in ways never before thought possible. And yet, still with similar resistance and controversy endured by Burzynski's Antineoplaston therapy. The film also takes you to Kurume University in Fukuoka, Japan—where independently designed studies of Antineoplastons have been underway for 27 years—without Dr. Burzynski's (the inventor's) involvement or supervision. Learn how this team of Japanese pathologists, oncologists and surgeons have studied these anti-cancer compounds using their own methodologies—resulting in the first ever independently-run randomized controlled clinical trials. "After twenty-seven years of independently testing Antineoplastons—including randomized clinical trials, we found that Dr. Burzynski was right. It's obviously not anecdotal anymore." —Hideaki Tsuda, MD - 2013, Kurume Medical University, Fukuoka Prefecture, Japan The viewer will experience the turbulent process in which the industry utilizes its now usurped regulatory agency to both block Antineoplastons' Phase 3 clinical trial process—and orchestrate a group of "information hit-men". However, most notable of all—are the earth-shattering events that occurred upon the final days of producing this film which will leave you speechless. Yet, with so much to say, it is for you to witness the story and shocking conclusion in 'Burzynski: Cancer Is Serious Business, Part II'.
Burzynski: Cancer is Serious Business, Part II | 1hr : 46mins
Search information, ideas, subjects related to this story:
Send funds to team of this film/project:
NOTE: 100% of your funds are sent directly from here.
Contact/inquire about this film-project:
This storyteller has yet to share/set a wallet for the direct fund transfers.
Shall we send an email request on your behalf?